About Glaukos Corporation - GKOS
Glaukos Corporation is a medical device company that specializes in the development and commercialization of products and procedures designed to treat glaucoma, a chronic eye disease that can lead to vision loss. The company is known for its innovative Micro-Invasive Glaucoma Surgery (MIGS) devices, which aim to reduce intraocular pressure in glaucoma patients with less invasive techniques compared to traditional surgeries.
What are Glaukos Corporation's core values and mission statement?
Glaukos Corporation is committed to pioneering new technologies and products designed to transform the treatment of glaucoma and related eye diseases. Their mission includes a dedication to improving the quality of life for patients worldwide by advancing the standard of care in ophthalmic diseases.
Who founded Glaukos Corporation and when?
Glaukos Corporation was founded by Mory Gharib, Olav Bergheim, and Richard Hill in 1998.
Who leads Glaukos Corporation?
As of the last update, Thomas Burns served as the CEO and President of Glaukos Corporation.
Where is Glaukos Corporation located, and what is its base country?
Glaukos Corporation is based in San Clemente, California, United States.
On which exchanges is Glaukos Corporation traded?
Glaukos Corporation is traded on the New York Stock Exchange (NYSE) under the ticker symbol "GKOS."
Glaukos Corporation (GKOS) Price Live Data
The live price of Glaukos Corporation (GKOS) is $92.65, with a trading volume of 401,756 in the last 24 hours. Wrapstocks updates the GKOS price in real-time. Glaukos Corporation is down -0.97% in the last 24 hours. The company has a live market cap of $4,521,038,848.00 and a supply of 48,799,599 GKOS stocks.
Glaukos Corporation (GKOS) is traded on New York Stock Exchange, and currently, the market is closed; trading will be resumed in 6 hours and 49 minutes.